Elinor Karlsson to TOR Serine-Threonine Kinases
This is a "connection" page, showing publications Elinor Karlsson has written about TOR Serine-Threonine Kinases.
Connection Strength
0.653
-
Karlsson E, Magic I, Bostner J, Dyrager C, Lysholm F, Hallbeck AL, St?l O, Lundstr?m P. Revealing Different Roles of the mTOR-Targets S6K1 and S6K2 in Breast Cancer by Expression Profiling and Structural Analysis. PLoS One. 2015; 10(12):e0145013.
Score: 0.471
-
Bostner J, Karlsson E, Pandiyan MJ, Westman H, Skoog L, Fornander T, Nordenskj?ld B, St?l O. Activation of Akt, mTOR, and the estrogen receptor as a signature to predict tamoxifen treatment benefit. Breast Cancer Res Treat. 2013 Jan; 137(2):397-406.
Score: 0.096
-
Karlsson E, Waltersson MA, Bostner J, P?rez-Tenorio G, Olsson B, Hallbeck AL, St?l O. High-resolution genomic analysis of the 11q13 amplicon in breast cancers identifies synergy with 8p12 amplification, involving the mTOR targets S6K2 and 4EBP1. Genes Chromosomes Cancer. 2011 Oct; 50(10):775-87.
Score: 0.087